2020 / 03

DOI: 10.47183/mes.2020.013

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ

COVID-19: внелегочные проявления у пациентов (собственные данные инфекционного госпиталя ФГБУ ФСНКЦ ФМБА России)

В. Г. Абрамов, Т. В. Гайгольник, А. О. Фетисов, В. Н. Пинжина, Т. М. Осипова, А. Ф. Безденежных, Д. Н. Морозов
Информация об авторах

ФГБУ «Федеральный Сибирский научно-клинический центр Федерального медико-биологического агентства», г.Красноярск, Россия

Статья получена: 09.07.2020 Статья принята к печати: 13.08.2020 Опубликовано online: 22.09.2020
|
  1. Hoffmann M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor //Cell. – 2020.
  2. 2.Raj V. S. et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC //Nature. – 2013. – Т. 495. – №. 7440. – С. 251-254.
  3. Wang K. et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein //BioRxiv. – 2020.
  4. Baig A. M. Neurological manifestations in COVID‐19 caused by SARS‐CoV‐2 //CNS neuroscience & therapeutics. – 2020. – Т. 26. – №. 5. – С. 499.
  5. Ding Y. et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways //The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland. – 2004. – Т. 203. – №. 2. – С. 622-630.
  6. Gu J. et al. Multiple organ infection and the pathogenesis of SARS //Journal of Experimental Medicine. – 2005. – Т. 202. – №. 3. – С. 415-424.
  7. Xu X. et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SArS-Cov-2) outside of Wuhan, China: retrospective case series BMJ, 368 (2020), p. m606
  8. Miller A. J., Arnold A. C. The renin–angiotensin system in cardiovascular autonomic control: recent developments and clinical implications //Clinical Autonomic Research. – 2019. – Т. 29. – №. 2. – С. 231-243.
  9. Chen T. L. et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study //The Journals of Gerontology: Series A. – 2020.
  10. Lechien J. R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study //European Archives of Oto-Rhino-Laryngology. – 2020. – С. 1-11.
  11. Zhou L. et al. Sars-Cov-2: Underestimated damage to nervous system //Travel Med Infect Dis. – 2020. – Т. 101642. – №. 10.1016.
  12. Moriguchi T. et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 //International Journal of Infectious Diseases. – 2020.
  13. Yeh E. A. et al. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis //Pediatrics. – 2004. – Т. 113. – №. 1. – С. e73-e76.
  14. Reinhold A.K., . Rittner H.L Barrier function in the peripheral and central nervous system—a review Pflugers Arch, 469 (2017), pp. 123-134
  15. Mehta P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression //Lancet (London, England). – 2020. – Т. 395. – №. 10229. – С. 1033.
  16. Zhao H. et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? //The Lancet Neurology. – 2020. – Т. 19. – №. 5. – С. 383-384.
  17. Toscano G. et al. Guillain–Barré syndrome associated with SARS-CoV-2 //New England Journal of Medicine. – 2020.
  18. Gutiérrez-Ortiz C. et al. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 //Neurology. – 2020.
  19. Leung W. K. et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection //Gastroenterology. – 2003. – Т. 125. – №. 4. – С. 1011-1017.
  20. Dimitrov D. S. The secret life of ACE2 as a receptor for the SARS virus //Cell. – 2003. – Т. 115. – №. 6. – С. 652-653.
  21. 21.Oudit G. Y. et al. SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS //European journal of clinical investigation. – 2009. – Т. 39. – №. 7. – С. 618-625.
  22. Kissling S. et al. Collapsing glomerulopathy in a COVID-19 patient //Kidney International. – 2020.
  23. . Кожиева М. Х. и др. Кишечная микробиота человека и рассеянный склероз //Журнал неврологии и психиатрии им. СС Корсакова. Спецвыпуски. – 2017. – Т. 117. – №. 10. – С. 11-19.
  24. Keely S. et al. Activated fluid transport regulates bacterial-epithelial interactions and significantly shifts the murine colonic microbiome //Gut microbes. – 2012. – Т. 3. – №. 3. – С. 250-260.
  25. Dumas A. et al. The role of the lung microbiota and the gut–lung axis in respiratory infectious diseases //Cellular microbiology. – 2018. – Т. 20. – №. 12. – С. e12966.